Caspase-14 is an anti-apoptotic protein targeting apoptosis-inducing factor in lung adenocarcinomas

Oncology Reports

Volumn 26, Issue 2, 2011, Pages 359-369

  Fang, Hsin Yuan ^a,b   Chen, Chih Yi ^b   Hung, Min Fa ^d   Hsiao, Yi Ting ^d   Chiang, Ting Chieh ^d   Lin, Tze Yi ^c   Chang, Hui Wen ^c   Chow, Kuan Chih ^d   Ko, Wen Je ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

Author keywords

Anti apoptosis; Apoptosis inducing factor; Caspase 14; Cisplatin resistance; Lung adenocarcinoma

Indexed keywords

APOPTOSIS INDUCING FACTOR; CASPASE 14; CISPLATIN; MONOCLONAL ANTIBODY;

ADULT; ANTIBODY SPECIFICITY; ARTICLE; CANCER STAGING; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LUNG ADENOCARCINOMA; LYMPH VESSEL; MAJOR CLINICAL STUDY; MALE; METASTASIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; TUMOR GROWTH;

ADENOCARCINOMA; AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; APOPTOSIS; APOPTOSIS INDUCING FACTOR; APOPTOSIS REGULATORY PROTEINS; CASPASE 14; CELL LINE, TUMOR; CISPLATIN; COHORT STUDIES; FEMALE; HELA CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MICE; MICE, INBRED BALB C; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; NEOPLASM RECURRENCE, LOCAL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SURVIVAL RATE; TRANSFECTION;

EID: 79958193513     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2011.1292     Document Type: Article

References (35)

1. Taylor RC, Cullen SP and Martin SJ: Apoptosis: controlled demolition at the cellular level. Nat Rev Mol Cell Biol 9: 231-241, 2008. (Pubitemid 351301823)
2. Clarke PG: Developmental cell death: morphological diversity and multiple mechanisms. Anat Embryol 181: 195-213, 1990.
3. Gozuacik D and Kimchi A: Autophagy as a cell death and tumor suppressor mechanism. Oncogene 23: 2891-2906, 2004. (Pubitemid 38638851)
4. Bras M, Yuste VJ, Roué G, et al: Drp1 mediates caspase-independent type III cell death in normal and leukemic cells. Mol Cell Biol 27: 7073-7088, 2007. (Pubitemid 47549746)
5. Lorenzo HK and Susin SA: Mitochondrial effectors in caspase-independent cell death. FEBS Lett 557: 14-20, 2004. (Pubitemid 38115862)
6. Jaattela M and Tschopp J: Caspase-independent cell death in T lymphocytes. Nat Immunol 4: 416-423, 2003.
7. Susin SA, Lorenzo HK, Zamzami N, et al: Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 397: 441-446, 1999.
8. Daugas E, Susin SA, Zamzami N, et al: Mitochondrio-nuclear translocation of AIF in apoptosis and necrosis. FASEB J 14: 729-739, 2000. (Pubitemid 30198571)
9. Arnoult A, Gaume B, Karbowski M, Sharpe JC, Cecconi F and Youle RJ: Mitochondrial release of AIF and EndoG requires caspase activation downstream of Bax/Bak-mediated permeabilization. EMBO J 22: 4385-4399, 2003. (Pubitemid 37087193)
10. Wu J, Harris NL and Inge TH: Nuclear factor-kappa B and apoptosis inducing factor activation by doxorubicin analog WP744 in SH-SY5Y neuroblastoma cells. J Surg Res 122: 231-239, 2004. (Pubitemid 39535948)
11. Rodríguez-Hernández A, Brea-Calvo G, Fernández-Ayala DJ, Cordero M, Navas P and Sánchez-Alcázar JA: Nuclear caspase-3 and caspase-7 activation, and poly(ADP-ribose) polymerase cleavage are early events in camptothecin-induced apoptosis. Apoptosis 11: 131-139, 2006.
12. Chen JT, Huang CY, Chiang YY, et al: HGF increases cisplatin resistance via down-regulation of AIF in lung cancer cells. Am J Respir Cell Mol Biol 38: 559-565, 2008.
13. Chook YM and Blobel G: Karyopherins and nuclear import. Curr Opin Struct Biol 11: 703-715, 2001.
14. Van de Craen M, van Loo G, Pype S, et al: Identification of a new caspase homologue: caspase-14. Cell Death Differ 5: 838-846, 1998. (Pubitemid 28484394)
15. Chien AJ, Presland RB and Kuechle MK: Processing of native caspase-14 occurs at an atypical cleavage site in normal epidermal differentiation. Biochem Biophys Res Commun 296: 911-917, 2002.
16. Denecker G, Hoste E, Gilbert B, et al: Caspase-14 protects against epidermal UVB photodamage and water loss. Nat Cell Biol 9: 666-674, 2007. (Pubitemid 47214729)
17. Koenig U, Sommergruber W and Lippens S: Aberrant expression or caspase-14 in epithelial tumors. Biochem Biophys Res Commun 335: 309-313, 2005. (Pubitemid 41140222)
18. Krajewska M, Kim H, Shin E, et al: Tumor-associated alterations in caspase-14 expression in epithelial malignancies. Clin Cancer Res 11: 5462-5471, 2005. (Pubitemid 41060822)
19. Chen JT, Lin TS, Chow KC, et al: Cigarette smoking induces overexpression of HGF in type II pneumocytes and lung cancer cells. Am J Respir Cell Mol Biol 34: 264-273, 2006.
20. Brownson RC, Alavanja MC, Hock ET and Loy TS: Passive smoking and lung cancer in non-smoking women. Am J Public Health 82: 1525-1530, 1992.
21. Detterbeck FC, Boffa DJ and Tanoue LT: The new lung cancer staging system. Chest 136: 260-271, 2009.
22. Lippens S, Kockx M, Knaapen M, et al: Epidermal differentiation does not involve the pro-apoptotic executioner caspases, but is associated with caspase-14 induction and processing. Cell Death Differ 7: 1218-1224, 2000. (Pubitemid 32042229)
23. Remmele W and Schicketanz KH: Immunohistochemical determination of estrogen and progesterone receptor content in human breast cancer. Computer-assisted image analysis (QIC score) vs. subjective grading (IRS). Pathol Res Pract 189: 862-866, 1993.
24. Kaplan EL and Meier P: Non-parametric estimation from incomplete observations. J Am Stat Assoc 53: 457-481, 1958.
25. Mantel N: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50: 163-170, 1966.
26. Kamer I, Sarig RH, Zaltsman Y, et al: Proapoptotic BID is an ATM effector in the DNA-damage response. Cell 122: 593-603, 2005. (Pubitemid 41191157)
27. Zinkel SS, Hurov KE, Ong C, Abtahi FM, Gross A and Korsmeyer SJ: A role for proapoptotic BID in the DNA-damage response. Cell 122: 579-591, 2005. (Pubitemid 41191156)
28. Burton TR, Henson ES, Baijal P, Eisenstat DD and Gibson SB: The pro-cell death Bcl-2 family member, BNIP3, is localized to the nucleus of human glial cells: Implications for glioblastoma multiforme tumor cell survival under hypoxia. Int J Cancer 118: 1660-1669, 2006. (Pubitemid 43376429)
29. Zermati Y, Mouhamad S, Stergiou L, et al: Non-apoptotic role for Apaf-1 in the DNA damage checkpoint. Mol Cell 28: 624-637, 2007. (Pubitemid 350137804)
30. Bartek J, Bartkova J and Lukas J: DNA damage signalling guards against activated oncogenes and tumour progression. Oncogene 26: 7773-7779, 2007. (Pubitemid 350242463)
31. Kaur M, Pop M, Shi D, Brignone C and Grossman SR: hHR23B is required for genotoxic-specific activation of p53 and apoptosis. Oncogene 26: 1231-1237, 2007.
32. Dominguez-Brauer C, Chen YJ, Brauer PM, Pimkina J and Raychaudhuri P: ARF stimulates XPC to trigger nucleotide excision repair by regulating the repressor complex of E2F4. EMBO Rep 10: 1036-1042, 2009.
33. Chiang YY, Chen SL, Hsiao YT, et al: Nuclear expression of dynamin-related protein 1 in lung adenocarcinomas. Mod Pathol 22: 1139-1150, 2009.
34. Luo SW, Zhang C, Zhang B, et al: Regulation of heterochromatin remodeling and myogenin expression during muscle differentiation by FAK interaction with MBD2. EMBO J 28: 2568-2582, 2009.
35. Lim ST, Chen XL, Lim Y, et al: Nuclear FAK promotes cell proliferation and survival through FERM-enhanced p53 degradation. Mol Cell 29: 9-22, 2008.